CONMED CorporationCNMDNYSE
Loading
EBITDA Margin Over TimeContracting
Percentile Rank21
3Y CAGR+158.2%
5Y CAGR-1.3%
Year-over-Year Change
EBITDA as a percentage of revenue
3Y CAGR
+158.2%/yr
vs -53.2%/yr prior
5Y CAGR
-1.3%/yr
Recent acceleration
Acceleration
+211.3pp
Accelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | 12.84% | -38.4% |
| 2024 | 20.82% | +34.7% |
| 2023 | 15.46% | +1973.1% |
| 2022 | 0.75% | -95.8% |
| 2021 | 17.74% | +29.4% |
| 2020 | 13.71% | -10.4% |
| 2019 | 15.31% | -1.1% |
| 2018 | 15.48% | +16.9% |
| 2017 | 13.25% | +12.3% |
| 2016 | 11.79% | - |